Magnetar Financial LLC Invests $1.89 Million in Integer Holdings Corporation $ITGR

Magnetar Financial LLC purchased a new position in shares of Integer Holdings Corporation (NYSE:ITGR) during the third quarter, Holdings Channel reports. The firm purchased 18,295 shares of the medical equipment provider’s stock, valued at approximately $1,890,000.

Several other large investors also recently added to or reduced their stakes in the stock. Alliancebernstein L.P. increased its holdings in shares of Integer by 885.1% during the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock worth $136,016,000 after buying an additional 993,810 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new position in Integer during the 3rd quarter worth about $41,938,000. William Blair Investment Management LLC purchased a new position in shares of Integer in the third quarter valued at approximately $28,459,000. Tributary Capital Management LLC boosted its position in Integer by 92.6% in the 3rd quarter. Tributary Capital Management LLC now owns 499,776 shares of the medical equipment provider’s stock valued at $51,642,000 after buying an additional 240,226 shares during the period. Finally, Millennium Management LLC grew its stake in Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after purchasing an additional 118,224 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ITGR has been the subject of a number of analyst reports. Truist Financial boosted their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Wells Fargo & Company raised their price target on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, February 20th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $101.00 target price on shares of Integer in a research note on Monday, February 23rd. Four investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $102.00.

Integer Price Performance

Integer stock opened at $83.43 on Friday. The stock has a market capitalization of $2.87 billion, a P/E ratio of 29.07, a P/E/G ratio of 1.46 and a beta of 0.75. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. Integer Holdings Corporation has a 12-month low of $62.00 and a 12-month high of $127.56. The firm’s 50-day moving average is $85.11 and its two-hundred day moving average is $86.18.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06. The company had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Equities analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Key Stories Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Board appointments and cooperation with an activist: Integer added James Flanagan as an independent director and agreed to a cooperation arrangement with Irenic Capital, which led to Aaron Kapito joining the board — a development that can accelerate governance/strategy reviews and is often viewed as a potential catalyst for shareholder value. Integer Appoints James Flanagan and Aaron Kapito to Board of Directors
• Positive Sentiment: Zacks raised longer-term estimates: Zacks Research increased its FY2027 and FY2028 EPS forecasts (FY2027 to $6.95 from $6.73; FY2028 to $7.57), signaling improved visibility for multi-year earnings power that can support a higher valuation if execution holds.
• Neutral Sentiment: Mixed quarter-level tweaks: Zacks lifted several quarterly estimates (notably Q2 2026 and Q4 2026/Q4 2027) while trimming others — these offsetting adjustments suggest analysts are refining timing of recovery/growth rather than changing the broad outlook dramatically.
• Negative Sentiment: Near-term cuts and a slight FY2026 trim: Zacks cut Q1 2026 (to $1.31 from $1.39) and trimmed Q3 2026 estimates modestly, and nudged FY2026 down to $6.40 (from $6.41). These near-term downgrades could pressure sentiment and earnings expectations for the next few quarters.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.